Clinical controlled trial in advanced breast cancer: CMFV (cyclophosphamide, methotrexale, fluorouracil, vincristine) versus CD (carminomycin, dibromodulcitol).
Chicago Style (17th ed.) CitationClinical Controlled Trial in Advanced Breast Cancer: CMFV (cyclophosphamide, Methotrexale, Fluorouracil, Vincristine) Versus CD (carminomycin, Dibromodulcitol).
MLA (9th ed.) CitationClinical Controlled Trial in Advanced Breast Cancer: CMFV (cyclophosphamide, Methotrexale, Fluorouracil, Vincristine) Versus CD (carminomycin, Dibromodulcitol).
Warning: These citations may not always be 100% accurate.
